© 1995 British Society for Rheumatology
research-article |
THE OCCURRENCE, NATURE AND DISTRIBUTION OF FLARES IN A COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A RHEUMATOLOGICAL VIEW
Division of Rheumatology, Department of Medicine, University College London London
Correspondence to:
Correspondence to: M. Ehrenstein, Department of Rheumatology Research, University College London Medical School, Arthur Stanley House, 4050 Tottenham Street, London W1P 9PG.
This study examines the occurrence, nature and distribution of disease flares in systemic lupus erythematosus (SLE) according to organ involvement. One-hundred-and-fourteen patients were seen in the Lupus Clinic of the Bloomsbury Rheumatology Unit over a 3-yr period. At each visit a data sheet was completed to assess their disease activity in eight separate organs/systems according to the British Isles Lupus Assessment Group (BILAG) activity index. This information was entered into a computer and a score for each organ system was obtained. The record of each individual patient was examined to identify flares in the individual organs; 458 flares occurred in 107 patients. The majority of patients (69%) experienced more than one flare during the study period. Fifty-four per cent of patients had flares in more than one system simultaneously, but the majority (70%) of flares involved only one system. The most severe organ involvement (A score)was most commonly observed in the musculoskeletal system, whereas severe renal disease occurred only three times. These results indicate that although SLE is a multisystem disease, the flares that occur tend to be confined to one system at a time. Further, these results demonstrate that in our rheumatology practice the most common A flare observedwas severe polyarthritis (A score in musculoskeletal).
KEY WORDS: Systemic lupus erythematosus, Flares, BILAG, Arthritis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A M Bertoli, G S Alarcon, G McGwin, M Fernandez, H M Bastian, B J Fessler, L M Vila, J D Reveille, and LUMINA Study Group Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity Lupus, January 1, 2006; 15(1): 13 - 18. [Abstract] [PDF] |
||||
![]() |
D. A. Isenberg, A. Rahman, E. Allen, V. Farewell, M. Akil, I. N. Bruce, D. D'Cruz, B. Griffiths, M. Khamashta, P. Maddison, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus Rheumatology, July 1, 2005; 44(7): 902 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gordon, N. Sutcliffe, J. Skan, T. Stoll, and D. A. Isenberg Definition and treatment of lupus flares measured by the BILAG index Rheumatology, November 1, 2003; 42(11): 1372 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Petri, J. Buyon, and M. Kim Classification and definition of major flares in SLE clinical trials Lupus, October 1, 1999; 8(8): 685 - 691. [Abstract] [PDF] |
||||

